pALD | New HIV Drugs v2

Dec 14, 2023

Planning Considerations for the Introduction of pALD

This slide deck, presented by CHAI at IPHASA 2023, outlines planning considerations for the introduction of pALD throughout all stages of...

Jun 5, 2023

Pediatric ALD (pALD) FAQs

This document is meant to answer some of the most common questions surround the fixed-dose combination of pediatric...

May 30, 2023

pALD Product Profile

This product profile provides a clinical overview of the fixed-dose combination of pediatric abacavir/lamivudine/ dolutegravir 60/30/5 mg...

May 24, 2023

GAP-f pALD Introduction and Rollout Planning Considerations for National Programmes

The GAP-f pDTG task team has developed a brief outlining product introduction and rollout considerations for national programmes when...

HIV New Product Introduction Toolkit